2026 AHNS/AAO-HNSF Translational Innovator Award
Funds innovative translational research by academic head and neck surgeons focused on neoplastic disease, emphasizing biomarker-driven projects and interdisciplinary collaboration.
Funder: American Academy of Otolaryngology - Head and Neck Surgery
Due Dates (Anticipated): December 2026 (Letter of Intent) | January 2027 (Full Application)
Funding Amounts: Up to $100,000 total over 24 months (non-renewable).
Summary: Supports innovative translational research by academic head and neck surgeons focused on neoplastic disease, with emphasis on biomarker-driven projects.
Description
This award funds contemporary basic or clinical research on neoplastic disease by full-time academic head and neck surgeons. The focus is on supporting novel translational research, especially projects involving biomarker concepts. Applicants are encouraged to propose studies that introduce new knowledge or methodologies from other disciplines or demonstrate collaborative efforts across related fields. The program prioritizes innovative projects with the potential to develop into long-term research programs capable of attracting further funding. An explicit career development plan leveraging institutional resources is required.
